ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Acadia Pharmaceuticals Inc.
Related studies linked through entity extraction aliases.
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
- Status
- RECRUITING
- Phase
- PHASE2
OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome
- Status
- TERMINATED
- Phase
- PHASE3
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
ACP-204 in Adults With Alzheimer's Disease Psychosis
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
- Status
- RECRUITING
- Phase
- PHASE4